Supriya Lifescience closes trading window until Q1FY27 results

0 min read     Updated on 21 Jun 2026, 01:01 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Supriya Lifescience Ltd. has closed its trading window for insiders and designated persons from July 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter ending June 30, 2026, in compliance with SEBI regulations. The board meeting date for Q1FY27 results will be announced later.

powered bylight_fuzz_icon
43500943

*this image is generated using AI for illustrative purposes only.

Supriya Lifescience Ltd. has closed its trading window for all insiders and designated persons effective July 1, 2026, to prevent potential insider trading ahead of its quarterly financial announcement. The restriction will remain in force until 48 hours after the company declares its unaudited financial results for the quarter ending June 30, 2026. This measure is in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the company's internal code of conduct.

The closure applies to securities of supriya lifescience and covers insiders, designated persons, and their immediate relatives as defined in the code. The company stated that the specific date for the board meeting to consider and declare the unaudited financial results for Q1FY27 will be communicated in due course.

Trading Window Schedule

Event Date
Trading window closure July 01, 2026
Quarter end June 30, 2026
Trading window reopens 48 hours after results declaration

Historical Stock Returns for Supriya Lifescience

1 Day5 Days1 Month6 Months1 Year5 Years
-0.01%-0.51%+36.29%+27.61%+38.96%+138.51%

What market performance does Supriya Lifescience anticipate for Q1FY27 given the early implementation of trading restrictions?

How might the extended trading window closure impact liquidity and stock volatility ahead of the earnings announcement?

Will the company provide any guidance or strategic updates alongside the unaudited financial results for the quarter?

Supriya Lifescience to host analyst meet on June 18

0 min read     Updated on 16 Jun 2026, 04:45 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Supriya Lifescience Limited has scheduled a virtual group meeting with analysts and institutional investors for June 18, 2026, between 02:00 PM and 03:00 PM IST. The meeting is conducted under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the Investor Presentation has been uploaded to the company website and stock exchanges.

powered bylight_fuzz_icon
43053688

*this image is generated using AI for illustrative purposes only.

Supriya Lifescience Limited will host a virtual group meeting with analysts and institutional investors on June 18, 2026. The interaction is scheduled between 02:00 PM and 03:00 PM IST, providing a platform for the company's officials to engage with Kotak PCG clients.

The meeting follows the relevant provisions of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015. As part of the disclosure process, the company has made the Investor Presentation available to the public. The document has been uploaded on the website of supriya lifescience and submitted to the stock exchanges.

Meeting Details

The schedule for the interaction is outlined below:

Sr. No. Meeting with Date & Time Format Mode
1. Group Meeting with Kotak PCG Clients Thursday, June 18, 2026
02:00 PM – 03:00 PM
Group Meeting Virtual

The company noted that the scheduled date is subject to change due to exigencies on the part of the company or the analysts and investors involved. This information was submitted to the exchanges pursuant to Regulation 30(6) of the SEBI Listing Regulations.

Historical Stock Returns for Supriya Lifescience

1 Day5 Days1 Month6 Months1 Year5 Years
-0.01%-0.51%+36.29%+27.61%+38.96%+138.51%

What key strategic updates or growth drivers is Supriya Lifescience expected to highlight during the meeting?

How might the outcomes of this meeting influence investor sentiment and stock performance in the short term?

Will the company provide guidance on future earnings or upcoming product launches in the investor presentation?

More News on Supriya Lifescience

1 Year Returns:+38.96%